Artgen Biotech PJSC (MOEX:ISKJ)

Artgen Biotech PJSC Revenue

In the year 2024, Artgen Biotech PJSC had annual revenue of 1.52B RUB with 11.18% growth. Artgen Biotech PJSC had revenue of 745.12M in the half year ending June 30, 2024, with 43.32% growth.

• Revenue: 1.52B
• Revenue Growth: +11.18%
• P/S Ratio: 2.82
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.29B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.52B	152.94M	11.18%
Dec 31, 2023	1.37B	231.65M	20.38%
Dec 31, 2022	1.14B	-43.89M	-3.72%
Dec 31, 2021	1.18B	96.77M	8.93%
Dec 31, 2020	1.08B	248.45M	29.73%